← Back
Gyre Therapeutics
GYRE · listed on Nasdaq · worth $683.65 million
$6.53
−28.86% on Oct 30
No insider bought Gyre Therapeutics stock in the last year. They sold it 13 times, $634.1K in all.
Red dot = an insider soldA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
35.9M shares
34% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, one insider sold Gyre Therapeutics stock and none bought. None of the 13 sales is marked on its filing as planned in advance; all by company executives.
All reports
Every insider trade and SEC report we hold for Gyre Therapeutics.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
12 more with Pro →Analysts, earnings and news
Analysts' price target
$18.67 average
3 analysts
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected
2 of 4 quarters above
Q2 '26−$0.12 a share−$0.06
Q1 '26−$0.10 a share−$0.03
Q4 '25$0.05 a share+$0.04
Q3 '25$0.03 a share+$0.05